BioMedomics develops point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology.
Employment range in NC
Primary site activity
All company activities
Potential end market(s)
Products on market
Biosensor based cell assay system, RNAi related products and services, highly sensitive point of care diagnostic devices for Sickle Cell Disease, alpha-Thalassemia, and quantative hemoglobin measurement
Products under development
Highly sensitive point of care diagnostic devices, including lateral-flow tests and quantitative time-resolved lateral-flow immunoassays, including a rapid test to diagnose novel coronavirus (COVID-19).